Zymeworks Inc. · NASDAQ:ZYME

Moore Paul Andrew sold 39,741 Zymeworks Inc. shares (Form 4)

Traded Nov 13, 2026 · Filed Nov 16, 2026

On Nov 13, 2026, Moore Paul Andrew (Chief Scientific Officer) sold 39,741 Zymeworks Inc. shares at an average US$26.07 for US$1.04M, leaving 33,756 shares. Filed Nov 16, 2026 (Form 4).

Sold
39,741 shares
Price
US$26.07 average (US$26.04 to US$26.14)
Value
US$1.04M
Holding after
33,756 shares
Trading plan
No
Role
Chief Scientific Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Nov 13, 2026Common StockOption exercise25,000US$5.8273,497Direct
Nov 13, 2026Common StockSale7,367US$26.1466,130Direct
Nov 13, 2026Common StockSale7,374US$26.0958,756Direct
Nov 13, 2026Common StockSale25,000US$26.0433,756Direct

Source

Download original · View original at SEC

Related